Study on the Apoptosis of Multiple Myeloma Cells Induced by Agonist Monoclonal Antibody Against Human CD28

邱玉华,赵文宝,孙中文,於葛华,石云杰,朱华亭,谢炜,张学光
DOI: https://doi.org/10.3969/j.issn.1001-2478.2003.06.005
2003-01-01
Abstract:To investigate the induction of apoptosis of multiple myeloma (MM)cells by agonist monoclonal antibody against human CD28 (AmAbCD28),the U266 and XG-1 cell lines,abnormally expressing the CD28 molecule,were chosen as target for the investigation of effect of AmAbCD28 on their growth and proliferation. This antibody was added to the media of culture system of cell lines (10 μg/ml),and the cell counts and trypan blue exclusion assay were performed daily thereafter. The experimental results demonstrated the inhibition of growth and proliferation of the U266 and XG-1 cells with increase of trypan blue colored cells. 24~48 hours after addition of the agonist CD28 monoclonal antobody,30% of the cells in culture appeared to have the pathological changes of early apoptosis,and after 72 hours,50% of cells showed the appearance of vacoules,apoptosis bodies and DNA ladder bands. These results suggest that the agonist CD28 monoclonal antibody can induce the apoptosis of multiple myeloma cells in vitro,and it might have significant value in clinical applications for biotherapy of multiple myeloma.
What problem does this paper attempt to address?